Dr Andrew Meythaler, AUD in Vestavia Hills, AL - Audiologist

Dr Andrew Meythaler, AUD is a Audiologist based in Vestavia Hills, Alabama. Dr Andrew Meythaler is licensed to practice in Alabama (license number 1321A) and his current practice location is 2017 Canyon Rd Ste 17, Vestavia Hills, Alabama. He can be reached at his office (for appointments etc.) via phone at (205) 482-0991.

NPI number for Dr Andrew Meythaler is 1740905215 and his current mailing address is 2017 Canyon Rd Ste 17, Vestavia Hills, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1740905215.

Contact Information

	Dr Andrew Meythaler, AUD
	2017 Canyon Rd Ste 17, Vestavia Hills, AL 35216-1928
	(205) 482-0991
	Not Available

Healthcare Provider's Profile

Full Name	Dr Andrew Meythaler
Gender	Male
Speciality	Audiologist
Location	2017 Canyon Rd Ste 17, Vestavia Hills, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1740905215
Provider Enumeration Date: 10/07/2022
Last Update Date: 10/07/2022

Medical Identifiers

Medical identifiers for Dr Andrew Meythaler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740905215	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	1321A (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Andrew Meythaler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Andrew Meythaler, AUD 2017 Canyon Rd Ste 17, Vestavia Hills, AL 35216-1928 Ph: (205) 482-0991	Dr Andrew Meythaler, AUD 2017 Canyon Rd Ste 17, Vestavia Hills, AL 35216-1928 Ph: (205) 482-0991

News Archive

Genetic risk factor for schizophrenia can disrupt connectivity at level of single neurons

The strongest known recurrent genetic cause of schizophrenia impairs communications between the brain's decision-making and memory hubs, resulting in working memory deficits, according to a study in mice.

ARCA biopharma submits Gencaro trial protocol for review under the FDA's SPA process

ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator.

New research suggests that accumulation of amyloid-beta peptides in cerebral blood vessels causes vascular damage in Alzheimer's disease

New research suggests that accumulation of amyloid-â peptides in cerebral blood vessels, as opposed to the brain itself, may be a more important pathological mediator of Alzheimer's disease. Two independent yet related articles describe such findings in the August issue of The American Journal of Pathology.

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting today.

Seattle Genetics, Genentech expand antibody-drug conjugate collaboration

Seattle Genetics, Inc. announced today that it has expanded its antibody-drug conjugate (ADC) collaboration agreement with Genentech, Inc., a member of the Roche Group. Under the expanded agreement, Genentech will pay an upfront fee of $12 million for rights to utilize Seattle Genetics' ADC technology with additional antigens to be named by Genentech.

Audiologist in Vestavia Hills, AL

Jones Institute For Rehabilitative Audiology, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 300 Vestavia Pkwy, Suite 2300, Vestavia Hills, AL 35216 Phone: 205-795-2059 Fax: 205-823-7758
Mrs. Julibeth Marie Jones, AUD, CCC-A, FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 300 Vestavia Pkwy, Suite 2300, Vestavia Hills, AL 35216 Phone: 205-795-2059
Vulcan Audiology Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2017 Canyon Rd Ste 17, Vestavia Hills, AL 35216 Phone: 205-482-0991

Dr Andrew Meythaler, AUD - Audiologist in Vestavia Hills, AL